PLUS THERAPEUTICS Inc.
NASDAQ: PSTV
$4.26
+0.26
(+6.50%)
as on
PLUS THERAPEUTICS Inc. Stock Performance
as on July 14, 2026 at 6:59 am IST
Day's Low
Day's High
$4.02$4.36
5.63%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
$2.90$23.4331.92%
Downside
449.88%
Upside
PLUS THERAPEUTICS Inc. share price movements today
- Previous Close
- $4.00
- Open
- $4.04
- Volume
- 648.9K
- Day's Low - High
- $4.02 - $4.36
- 52 Week Low - High
- $2.90 - $23.43
PLUS THERAPEUTICS Inc. Historical Returns
- 1 Month Return
- -20.16 %
- 3 Month Return
- -26.34 %
- 1 Year Return
- -52.42 %
- 3 Year Return
- -92.27 %
- 5 Year Return
- -99.53 %
PLUS THERAPEUTICS Inc. Stock Fundamentals & Key Indicators
Check PLUS THERAPEUTICS Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$27.5M
EPS (TTM)
-3.9225
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.19
Industry PE ratio
-3.2497872340425533
PEG Ratio
2.4504
EBITDA
-18.5M
Revenue (TTM)
5.2M
Profit Margin
-230.24%
Return On Equity TTM
-522.50%
PLUS THERAPEUTICS Inc. Stock Valuation
Track how PLUS THERAPEUTICS Inc. P/E has moved over time to understand its valuation trends.
PLUS THERAPEUTICS Inc. in the last 5 years
Lowest (-3.37x)
March 31, 2026
Industry (-3.25x)
July 14, 2026
Today (0.19x)
July 14, 2026
Highest (-0.43x)
December 31, 2023
Today’s Price to Earnings Ratio: 0.19x
PLUS THERAPEUTICS Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of PLUS THERAPEUTICS Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $27.5M | -99.53% | 0.19 | -230.24% | NA | |
| BUY | $39.9B | 70.11% | 75.25 | 12.55% | NA | |
| BUY | $123.2B | 144.74% | 28.82 | 35.51% | NA | |
| BUY | $69.7B | 15.17% | 16.24 | 29.65% | 0.54% |
Stock Returns calculator for PLUS THERAPEUTICS Inc. Stock including INR - Dollar returns
The PLUS THERAPEUTICS Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
PLUS THERAPEUTICS Inc. investment value today
Current value as on today
₹56,306
Returns
Returns from PLUS THERAPEUTICS Inc. Stock
Dollar Impact
₹5,652 (+5.65%)
Analyst Recommendation on PLUS THERAPEUTICS Inc. Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for PLUS THERAPEUTICS Inc.. Average target price of $36
PLUS THERAPEUTICS Inc. Share Price Target
Get share price movements and forecasts by analysts on PLUS THERAPEUTICS Inc..
What analysts predicted
88.17%UPSIDE
Target Price
$36
Current Price
$4.26
Analyzed by
10 Analysts
Target
$36.00
PLUS THERAPEUTICS Inc. target price $36, a slight upside of 88.17% compared to current price of $4.26. According to 10 analysts rating.
Indian Investors' Interest in PLUS THERAPEUTICS Inc. Stock
Search interest for PLUS THERAPEUTICS Inc. Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
PLUS THERAPEUTICS Inc. Quarterly Profit & Loss
All numbers in Millions USD
PLUS THERAPEUTICS Inc. Annual Profit & Loss
All numbers in Millions USD
PLUS THERAPEUTICS Inc. Quarterly Cash Flow
All numbers in Millions USD
PLUS THERAPEUTICS Inc. Annual Cash Flow
All numbers in Millions USD
PLUS THERAPEUTICS Inc. News & Key Events
Today's Timeline - 30 June
Tue, 06:19 PM
-Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3, 2026, while affirming 2026 milestone guidance.
Insights on PLUS THERAPEUTICS Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 17.0% return, outperforming this stock by 72.5%
- NO EFFECT
Against Peers
In the last 3 years, PLUS THERAPEUTICS, Inc. Common Stock has experienced a drawdown of -92.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 84.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 1.39M → 1.02M (in $), with an average decrease of 13.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, PSTV stock has moved down by -20.2%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 5.15M → -6.94M (in $), with an average decrease of 78.9% per quarter
About PLUS THERAPEUTICS Inc.
| Organisation | PLUS THERAPEUTICS Inc. |
| Headquarters | 6420 LEVIT GREEN BOULEVARD, Houston, TX, United States, 77021 |
| Industry | Biotechnology |
| CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Key Management of PLUS THERAPEUTICS Inc.
Name | Title |
|---|---|
Dr. Marc H. Hedrick M.B.A., M.D. | President, CEO & Director |
Mr. Andrew J. Sims CPA | VP & CFO |
Mr. Russ Havranek M.B.A., M.S. | Executive Vice President of Commercial and Corporate Strategy |
Dr. Eric J. Daniels M.B.A., M.D. | Chief Development Officer |
Ms. Desiree Smith | Corporate Controller |
Mr. Russell W. Bradley | President & GM of CNSide Diagnostics, LLC |
FAQs
What is PLUS THERAPEUTICS Inc. share price today?
PLUS THERAPEUTICS Inc. share price today is $4.26 as on at the close of the market. PLUS THERAPEUTICS Inc. share today touched a day high of $4.36 and a low of $4.02.
What is the 52 week high and 52 week low for PLUS THERAPEUTICS Inc. share?
PLUS THERAPEUTICS Inc. share touched a 52 week high of $23.43 on and a 52 week low of $2.90 on . PLUS THERAPEUTICS Inc. stock price today i.e. is closed at $4.26,which is 81.81% down from its 52 week high and 46.90% up from its 52 week low.
What is PLUS THERAPEUTICS Inc.'s market capitalisation today?
PLUS THERAPEUTICS Inc. market capitalisation is $0.00T as on .
How to invest in PLUS THERAPEUTICS Inc. Stock (PSTV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for PLUS THERAPEUTICS Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PLUS THERAPEUTICS Inc. Shares that will get you 0.3521 shares as per PLUS THERAPEUTICS Inc. share price of $4.26 per share as on July 14, 2026 at 1:29 am IST.
What is the minimum amount required to buy PLUS THERAPEUTICS Inc. Stock (PSTV) from India?
Indian investors can start investing in PLUS THERAPEUTICS Inc. (PSTV) shares with as little as ₹95.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in PLUS THERAPEUTICS Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on PLUS THERAPEUTICS Inc. share’s latest price of $4.26 as on July 14, 2026 at 1:29 am IST, you will get 2.3474 shares of PLUS THERAPEUTICS Inc.. Learn more about
fractional shares .
What are the returns that PLUS THERAPEUTICS Inc. has given to Indian investors in the last 5 years?
PLUS THERAPEUTICS Inc. stock has given -99.53% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?